TrialAnnals of hematology2019

Daratumumab plus bortezomib, melphalan, and prednisone in East Asian patients with non-transplant multiple myeloma: subanalysis of the randomized phase 3 ALCYONE trial.

Tomoaki Fujisaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.